Nancy J Hutson - Net Worth and Insider Trading
Nancy J Hutson Net Worth
The estimated net worth of Nancy J Hutson is at least $755,366 dollars as of 2024-12-26. Nancy J Hutson is the Director of BioCryst Pharmaceuticals Inc and owns about 86,638 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $668,845. Nancy J Hutson is the Director of Clearside Biomedical Inc and owns about 93,000 shares of Clearside Biomedical Inc (CLSD) stock worth over $86,490. Nancy J Hutson is also the Director of Endo International PLC and owns about 49,970 shares of Endo International PLC (ENDPQ) stock worth over $30. Besides these, Nancy J Hutson also holds PhaseBio Pharmaceuticals Inc (PHASQ) . Details can be seen in Nancy J Hutson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy J Hutson has not made any transactions after 2024-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nancy J Hutson
Nancy J Hutson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy J Hutson owns 4 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) , Clearside Biomedical Inc (CLSD) , and PhaseBio Pharmaceuticals Inc (PHASQ) among others .
Click here to see the complete history of Nancy J Hutson’s form 4 insider trades.
Insider Ownership Summary of Nancy J Hutson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-12-13 | director |
| CLSD | Clearside Biomedical Inc | 2023-10-03 | director |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2021-08-18 | director |
 | | 2018-11-15 | director |
Nancy J Hutson Latest Holdings Summary
Nancy J Hutson currently owns a total of 4 stocks. Among these stocks, Nancy J Hutson owns 86,638 shares of BioCryst Pharmaceuticals Inc (BCRX) as of December 13, 2024, with a value of $668,845 and a weighting of 88.55%. Nancy J Hutson owns 93,000 shares of Clearside Biomedical Inc (CLSD) as of October 3, 2023, with a value of $86,490 and a weighting of 11.45%. Nancy J Hutson also owns 49,970 shares of Endo International PLC (ENDPQ) as of November 15, 2018, with a value of $30 and a weighting of 0%. The other 1 stocks PhaseBio Pharmaceuticals Inc (PHASQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Nancy J Hutson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-12-13 | 86,638 | 7.72 | 668,845 |
| CLSD | Clearside Biomedical Inc | 2023-10-03 | 93,000 | 0.93 | 86,490 |
| ENDPQ | Endo International PLC | 2018-11-15 | 49,970 | 0.00 | 30 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2021-08-18 | 4,000 | 0.00 | 0 |
Holding Weightings of Nancy J Hutson
Nancy J Hutson Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy J Hutson has made a total of 5 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 7,000 shares on December 13, 2024, which brought Nancy J Hutson around $52,780.
According to the SEC Form 4 filings, Nancy J Hutson has made a total of 5 transactions in Clearside Biomedical Inc (CLSD) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Clearside Biomedical Inc is the acquisition of 10,000 shares on October 3, 2023, which cost Nancy J Hutson around $8,600.
According to the SEC Form 4 filings, Nancy J Hutson has made a total of 0 transactions in Endo International PLC (ENDPQ) over the past 5 years. The most-recent trade in Endo International PLC is the sale of 10,000 shares on November 15, 2018, which brought Nancy J Hutson around $128,300.
More details on Nancy J Hutson's insider transactions can be found in the Insider Trading History of Nancy J Hutson table.Insider Trading History of Nancy J Hutson
- 1
Nancy J Hutson Trading Performance
GuruFocus tracks the stock performance after each of Nancy J Hutson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy J Hutson is 12.6%. GuruFocus also compares Nancy J Hutson's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy J Hutson within 3 months outperforms 4 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nancy J Hutson's insider trading performs compared to the benchmark.
Performance of Nancy J Hutson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.94 | | | | | |
| Relative Return to S&P 500(%) | 5.35 | | | | | |
Nancy J Hutson Ownership Network
Nancy J Hutson Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Nancy J Hutson is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Nancy J Hutson made 2 insider transaction in BioCryst Pharmaceuticals Inc (BCRX) with a net sale of 2,000. Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net purchase of 36,300 shares made by Anthony Doyle , a net purchase of 30,000 shares made by Jon P Stonehouse , and a net purchase of 30,000 shares made by Helen M. Thackray .
In summary, during the past 3 months, insiders sold 7,000 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 26,987 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 156,614 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Nancy J Hutson Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy J Hutson. You might contact Nancy J Hutson via mailing address: 64 Montauk Avenue, Stonington Ct 06378.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
